Beste OncoTalks podcasts (2025)

1
Advancing mCRC Care: Innovations and Insights in Modern Cancer Treatment 24:23

4d ago24:23

24:23

In this episode of OncoTalks, Dr. Paul Conkling and Dr. David Cosgrove explore the latest advancements in mCRC treatment, highlighting the shift from traditional chemotherapy to innovative targeted therapies driven by genomic insights. We discuss the role of next-generation sequencing, new therapeutic agents, and clinical trials, while emphasizing …

1
HER2-low Uncovered: A Phase 1 Retrospective Study on Testing & Concordant Treatment 17:47

16d ago17:47

17:47

Join us for the conclusion of our 2-part series on HER2-low breast cancer, featuring Dr. Paul Conkling and Dr. Erika Hamilton. They discuss the Phase 1 results from a HER2-low retrospective study evaluating HER2 testing patterns and concordant therapy in patients with HER2 metastatic breast cancer. Learn about the evolving role of HER2-low classifi…

1
Unlocking the Future of Breast Cancer Treatment and the Critical Role of HER2 Testing 11:10

3M ago11:10

11:10

Join us as we explore the transformative potential of HER2 testing in breast cancer care. In this episode of OncoTalks, Dr. Paul Conkling and Dr. Erika Hamilton share cutting-edge insights that every oncologist should know to stay at the forefront of breast cancer treatment. Tune in to discover how HER2 testing is reshaping the landscape of persona…

1
Genomic Testing in the Clinic 15:20

3M ago15:20

15:20

Join Dr. Robert Reid and Dr. Sreeni Chittoor as they explore the revolutionary impact of genomic testing in redefining cancer treatment. We focus on advanced solid tumors, such as non-small cell lung cancer (NSCLC), breast cancer, and colorectal cancer, examining how these state-of-the-art technologies are leading to more personalized and effective…

1
Exploring CAR-T Cell Therapy 11:26

3M ago11:26

11:26

Join Dr. Paul Conkling and Dr. Akash Mukherjee as they explore CAR-T Therapy from design of treatment through the patient journey.Door OntadaLearn

1
Bispecific Antibody Therapies in the Community for DLBCL and FL 24:19

4M ago24:19

24:19

Join Dr. Ira Zackon and Dr. David Andorsky on today’s episode of OncoTalks, as they discuss the expanding role of bispecific antibody therapies in the community for Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL).Door OntadaLearn

1
NSCLC METex14 Skipping 12:19

4M ago12:19

12:19

In this episode of OncoTalks, Dr. David Waterhouse and Dr. Paul Conkling discuss NSCLC and the groundbreaking developments in treating patients with MET exon 14 (METex14) skipping mutations. We review the science behind these targeted therapies, their clinical applications, and the impact on patient outcomes.…

1
Exploring Second Line Treatments for Extensive Stage Small Cell Lung Cancer 14:57

5M ago14:57

14:57

In this episode, Dr. David Waterhouse and Dr. Paul Conkling discuss the evolving landscape of second line treatments for extensive stage small cell lung cancer (SCLC). They review the latest research, promising therapies, and the impact of these treatments on patient quality of life. This episode offers vital information to help navigate treatment …

1
Managing Ocular Side Effects in ELAHERE Treatment 11:41

5M ago11:41

11:41

In this episode, Dr. Kristen Lamoreau, OD, delves into the critical role eye care professionals play in managing ocular adverse events for patients undergoing treatment with ELAHERE, the first and only antibody-drug conjugate targeting folate receptor alpha (FRα). As a groundbreaking treatment for certain types of resistant ovarian cancer, ELAHERE …

1
Management & Proactive Care in EGFR+ mNSCLC Treatment 11:02

6M ago11:02

11:02

Welcome to episode three of three. In this episode, Dr. Alex Spira and Dr. Josh Zabari, both experts in thoracic oncology, delve into the common side effects experienced by patients undergoing treatment for locally Advanced or Metastatic EGFR+ Non-Small Cell Lung Cancer (NSCLC). They discuss the importance of early identification and management of …

1
Resistance Mechanisms in EGFR+ mNSCLC 13:02

6M ago13:02

13:02

Welcome to episode two of three, where Dr. John Hamack from MD Anderson Cancer Center and Dr. Millie Doss from Stanford University discuss the latest advancements and ongoing challenges in treating locally Advanced or Metastatic EGFR+ Non-Small Cell Lung Cancer (NSCLC). Explore the unmet needs in first-line therapy, the variety of resistance mechan…

1
Unmet Needs in EGFR+ mNSCLC 13:24

6M ago13:24

13:24

Welcome to episode one of three, where we dive deep into the challenges and advancements in managing locally Advanced or Metastatic EGFR+ Non-Small-Cell Lung Cancer (NSCLC). Join Dr. Mark Socinski, Executive Medical Director of the Advent Health Cancer Institute, and Dr. David Waterhouse from Oncology Hematology Care in Cincinnati, Ohio, as they di…

Podcasts die het beluisteren waard zijn

OncoTalks Podcasts

Podcasts die het beluisteren waard zijn

1
OncoTalks | Oncology Insights at Your Fingertips

Ontada Learn

1
Advancing mCRC Care: Innovations and Insights in Modern Cancer Treatment 24:23

1
HER2-low Uncovered: A Phase 1 Retrospective Study on Testing & Concordant Treatment 17:47

1
Unlocking the Future of Breast Cancer Treatment and the Critical Role of HER2 Testing 11:10

1
Genomic Testing in the Clinic 15:20

1
Exploring CAR-T Cell Therapy 11:26

1
Bispecific Antibody Therapies in the Community for DLBCL and FL 24:19

1
NSCLC METex14 Skipping 12:19

1
Exploring Second Line Treatments for Extensive Stage Small Cell Lung Cancer 14:57

1
Managing Ocular Side Effects in ELAHERE Treatment 11:41

1
Management & Proactive Care in EGFR+ mNSCLC Treatment 11:02

1
Resistance Mechanisms in EGFR+ mNSCLC 13:02

1
Unmet Needs in EGFR+ mNSCLC 13:24

Korte handleiding